CA2649194C - Pharmaceutical composition that comprises an analgesic and vitamins - Google Patents
Pharmaceutical composition that comprises an analgesic and vitamins Download PDFInfo
- Publication number
- CA2649194C CA2649194C CA2649194A CA2649194A CA2649194C CA 2649194 C CA2649194 C CA 2649194C CA 2649194 A CA2649194 A CA 2649194A CA 2649194 A CA2649194 A CA 2649194A CA 2649194 C CA2649194 C CA 2649194C
- Authority
- CA
- Canada
- Prior art keywords
- ketorolac
- pharmaceutical composition
- composition according
- complex
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA/A/2006/004020 | 2006-04-10 | ||
MXPA/A/2006/004020A MXPA06004020A (en) | 2006-04-10 | Pharmaceutical composition comprising an analgesic and vitamins | |
PCT/IB2007/000907 WO2007116287A1 (es) | 2006-04-10 | 2007-04-10 | Composición farmacéutica que comprende la combinación de una sal de ketorolaco y vitaminas del complejo b para el tratamiento de la neuralgia. |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2649194A1 CA2649194A1 (en) | 2007-10-18 |
CA2649194C true CA2649194C (en) | 2014-12-30 |
Family
ID=38580737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2649194A Expired - Fee Related CA2649194C (en) | 2006-04-10 | 2007-04-10 | Pharmaceutical composition that comprises an analgesic and vitamins |
Country Status (16)
Country | Link |
---|---|
US (1) | US20090227534A1 (ja) |
EP (1) | EP2008655B1 (ja) |
JP (1) | JP5244089B2 (ja) |
AR (1) | AR060394A1 (ja) |
BR (1) | BRPI0709967A2 (ja) |
CA (1) | CA2649194C (ja) |
CO (1) | CO6331430A2 (ja) |
CR (1) | CR10360A (ja) |
DO (1) | DOP2007000055A (ja) |
EC (1) | ECSP088801A (ja) |
ES (1) | ES2428342T3 (ja) |
GT (1) | GT200800208A (ja) |
HN (1) | HN2008001531A (ja) |
PE (2) | PE20120122A1 (ja) |
PL (1) | PL2008655T3 (ja) |
WO (1) | WO2007116287A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2008003230A (es) * | 2008-03-07 | 2009-09-07 | Senosiain S A De C V Lab | Composicion famaceutica oral que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b. |
EP4190327A1 (en) * | 2010-10-21 | 2023-06-07 | Rtu Pharmaceuticals LLC | Ready to use ketorolac formulations |
AU2013201465B2 (en) * | 2012-10-24 | 2016-03-03 | Rayner Surgical (Ireland) Limited | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
TWI809304B (zh) | 2014-12-01 | 2023-07-21 | 奥默羅斯公司 | 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2823167A (en) * | 1955-03-29 | 1958-02-11 | Vitarine Co Inc | Stable vitamin b12-containing solution |
FR4492M (ja) * | 1965-07-07 | 1966-10-10 | ||
US4564614A (en) * | 1984-10-11 | 1986-01-14 | Pfizer Inc. | Antiinflammatory methods |
US6051587A (en) | 1998-04-16 | 2000-04-18 | Medicure, Inc. | Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein |
US20030191187A1 (en) * | 2002-04-01 | 2003-10-09 | Lee Fang Yu | Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same |
US9668972B2 (en) * | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
MXPA02010828A (es) | 2002-11-04 | 2004-07-16 | Leopoldo Espinosa Abdala | Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor. |
-
2007
- 2007-03-22 DO DO2007000055A patent/DOP2007000055A/es unknown
- 2007-04-09 PE PE2011001166A patent/PE20120122A1/es active IP Right Grant
- 2007-04-09 PE PE2007000424A patent/PE20080363A1/es not_active Application Discontinuation
- 2007-04-10 WO PCT/IB2007/000907 patent/WO2007116287A1/es active Application Filing
- 2007-04-10 JP JP2009504843A patent/JP5244089B2/ja not_active Expired - Fee Related
- 2007-04-10 PL PL07734226T patent/PL2008655T3/pl unknown
- 2007-04-10 BR BRPI0709967-3A patent/BRPI0709967A2/pt not_active IP Right Cessation
- 2007-04-10 US US12/226,219 patent/US20090227534A1/en not_active Abandoned
- 2007-04-10 AR ARP070101491A patent/AR060394A1/es not_active Application Discontinuation
- 2007-04-10 ES ES07734226T patent/ES2428342T3/es active Active
- 2007-04-10 EP EP07734226.9A patent/EP2008655B1/en not_active Not-in-force
- 2007-04-10 CA CA2649194A patent/CA2649194C/en not_active Expired - Fee Related
-
2008
- 2008-10-08 EC EC2008008801A patent/ECSP088801A/es unknown
- 2008-10-09 GT GT200800208A patent/GT200800208A/es unknown
- 2008-10-10 CO CO08108827A patent/CO6331430A2/es not_active Application Discontinuation
- 2008-10-10 CR CR10360A patent/CR10360A/es not_active Application Discontinuation
- 2008-10-10 HN HN2008001531A patent/HN2008001531A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP5244089B2 (ja) | 2013-07-24 |
JP2009533413A (ja) | 2009-09-17 |
PL2008655T3 (pl) | 2013-11-29 |
AR060394A1 (es) | 2008-06-11 |
ES2428342T3 (es) | 2013-11-07 |
PE20080363A1 (es) | 2008-05-25 |
CA2649194A1 (en) | 2007-10-18 |
PE20120122A1 (es) | 2012-03-09 |
CO6331430A2 (es) | 2011-10-20 |
EP2008655B1 (en) | 2013-06-26 |
GT200800208A (es) | 2010-03-18 |
CR10360A (es) | 2009-02-20 |
EP2008655A1 (en) | 2008-12-31 |
US20090227534A1 (en) | 2009-09-10 |
BRPI0709967A2 (pt) | 2011-08-02 |
WO2007116287A1 (es) | 2007-10-18 |
DOP2007000055A (es) | 2007-10-31 |
ECSP088801A (es) | 2009-01-30 |
HN2008001531A (es) | 2011-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chermy et al. | Cancer pain management current strategy | |
BRPI0613499A2 (pt) | formulação de comprimido farmacêutico de 1[(3-hidróxi-adamant -1-ilamino)- acetil]- pirrolidino-2 (s)-carbonitrila de liberação modificada, comprimido em multicamada, comprimido farmacêutico e cápsula contendo a mesma, processo de produção da mesma, seu uso, processo de preparação de comprimido bem como forma de dosagem farmacêutica | |
BG65502B1 (bg) | Фармацевтичен състав за лечение на остри неразположения и неговото използване | |
ES2435240T3 (es) | Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amlodipina, su preparación y su aplicación terapéutica | |
WO2006101745A2 (en) | Alpha7 neuronal nicotinic receptor ligand and antipsychotic compositions | |
TW200418474A (en) | Method of treating post-operative nausea and vomiting | |
CA2649194C (en) | Pharmaceutical composition that comprises an analgesic and vitamins | |
JPH0157093B2 (ja) | ||
CA2490147C (en) | Liquid dosage forms of non-enterically coated proton pump inhibitors | |
CN113230411B (zh) | 一种阿利沙坦酯或其盐与钙离子通道拮抗剂的复方药物组合物 | |
RU2261098C2 (ru) | Перорально распадающаяся композиция, содержащая миртазапин | |
BRPI0908988A2 (pt) | formulação galênica oral incluindo cetorolaco e vitaminas do complexo b, em que a vitamina b6 está em uma camada externa separada do resto dos princípios ativos | |
JP5811404B2 (ja) | セトロンを頬側経粘膜投与するための処方物(formulation) | |
KR20120104574A (ko) | 티보자닙과 템시롤리무스의 조합물 | |
Hersh et al. | Narcotic receptor blockade and its effect on the analgesic response to placebo and ibuprofen after oral surgery | |
MXPA06004020A (en) | Pharmaceutical composition comprising an analgesic and vitamins | |
US9186342B2 (en) | Combination of an NSAID and an amino acid | |
EP1553934A1 (en) | Pharmaceutical composition for treating pain comprising oxicarbazepine, or derivatives thereof, and cox2 inhibitors | |
WO2014017897A1 (es) | Nueva composición farmacéutica de liberación diferencial conteniendo tres principios activos | |
CN102335177B (zh) | 一种口服固体药用组合物及其制备方法 | |
EP3065718A1 (en) | Controlled-release formulations comprising torsemide | |
JP4344532B2 (ja) | 鼻炎用組成物 | |
US20060063813A1 (en) | Organic compounds | |
MX2011013989A (es) | Combinacion farmaceutica. | |
TW200838534A (en) | Treatment for irritable bowel syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20200831 |